For kidney transplant recipients with type 2 diabetes, use of glucagon-like peptide-1 receptor agonists was associated with ...

Empagliflozin patent expiration in India leads to affordable treatment for diabetes, heart failure, and kidney disease.

In summary, rosiglitazone may help control diabetes, but its serious impact on heart health makes it a risky choice. The Yale ...

Diabetes Canada is excited about Prince Edward Island's new pharmacare deal with the federal government, but hopes the ...

Okra water, made by soaking okra pods overnight, is beneficial for weight loss. It contains fiber, antioxidants, and ...

Tirzepatide — a drug that acts both as a GLP-1 agonist and a GIP agonist — is the active ingredient in an even more powerful ...

As the potential of GLP-1 agonists for addiction gains traction, big pharma is also starting to take notice, namely the two ...

Certain diabetes symptoms may contribute to hair loss, but more research is needed to explain why. Learn more about how it ...

Altimmune said on Thursday that it plans to test its lead experimental obesity drug, pemvidutide, to potentially treat ...

Tirzepatide and semaglutide were associated with larger QALY gains (incremental gains of 0.35 and 0.25 over lifestyle ...

Semaglutide and tirzepatide confer greater improvements in life expectancy than naltrexone/bupropion and ...

The UK healthcare landscape is set for a major shake-up following Prime Minister Keir Starmer’s announcement that NHS England ...